Morgan Stanley’s PLx Pharma Inc. Common Stock PLXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-179,616
| Closed | -$23.4K | – | 7825 |
|
|
2023
Q1 | $23.4K | Sell |
179,616
-10,197
| -5% | -$2.07K | ﹤0.01% | 6568 |
|
|
2022
Q4 | $31.1K | Sell |
189,813
-44,291
| -19% | -$18.5K | ﹤0.01% | 6499 |
|
|
2022
Q3 | $152K | Sell |
234,104
-436,906
| -65% | -$644K | ﹤0.01% | 5869 |
|
|
2022
Q2 | $1.63M | Sell |
671,010
-183,733
| -21% | -$510K | ﹤0.01% | 4688 |
|
|
2022
Q1 | $3.45M | Sell |
854,743
-3,749
| -0.4% | -$20.6K | ﹤0.01% | 4063 |
|
|
2021
Q4 | $6.88M | Buy |
858,492
+646,659
| +305% | +$7.58M | ﹤0.01% | 3377 |
|
|
2021
Q3 | $4.09M | Buy |
211,833
+129,229
| +156% | +$2.26M | ﹤0.01% | 3945 |
|
|
2021
Q2 | $1.14M | Buy |
82,604
+82,227
| +21,811% | +$974K | ﹤0.01% | 5006 |
|
|
2021
Q1 | $3K | Buy |
377
+127
| +51% | +$928 | ﹤0.01% | 7236 |
|
|
2020
Q4 | $1K | Hold |
250
| – | – | ﹤0.01% | 6991 |
|
|
2020
Q3 | $1K | Hold |
250
| – | – | ﹤0.01% | 6693 |
|
|
2020
Q2 | $1K | Hold |
250
| – | – | ﹤0.01% | 6547 |
|
|
2020
Q1 | $1K | Hold |
250
| – | – | ﹤0.01% | 6511 |
|
|
2019
Q4 | $1K | Sell |
250
-243
| -49% | -$1.14K | ﹤0.01% | 6609 |
|
|
2019
Q3 | $2K | Buy |
493
+205
| +71% | +$1.19K | ﹤0.01% | 6504 |
|
|
2019
Q2 | $2K | Buy |
288
+38
| +15% | +$206 | ﹤0.01% | 6488 |
|
|
2019
Q1 | $1K | Hold |
250
| – | – | ﹤0.01% | 6549 |
|
|
2018
Q4 | $0 | Hold |
250
| – | – | ﹤0.01% | 6797 |
|
|
2018
Q3 | $1K | Sell |
250
-132
| -35% | -$497 | ﹤0.01% | 6675 |
|
|
2018
Q2 | $1K | Hold |
382
| – | – | ﹤0.01% | 6623 |
|
|
2018
Q1 | $1K | Sell |
382
-70
| -15% | -$443 | ﹤0.01% | 6565 |
|
|
2017
Q4 | $3K | Sell |
452
-18
| -4% | -$125 | ﹤0.01% | 6417 |
|
|
2017
Q3 | $3K | Sell |
470
-76
| -14% | -$488 | ﹤0.01% | 6375 |
|
|
2017
Q2 | $3K | Buy |
546
+73
| +15% | +$534 | ﹤0.01% | 6428 |
|
|
2017
Q1 | $5K | Sell |
473
-30
| -6% | -$326 | ﹤0.01% | 6364 |
|
|
2016
Q4 | $6K | Sell |
503
-166
| -25% | -$6.1K | ﹤0.01% | 6257 |
|
|
2016
Q3 | $77K | Buy |
669
+1
| +0.1% | +$98 | ﹤0.01% | 5415 |
|
|
2016
Q2 | $53K | Sell |
668
-9
| -1% | -$780 | ﹤0.01% | 5513 |
|
|
2016
Q1 | $51K | Sell |
677
-583
| -46% | -$37.1K | ﹤0.01% | 5606 |
|
|
2015
Q4 | $112K | Sell |
1,260
-1,075
| -46% | -$103K | ﹤0.01% | 5347 |
|
|
2015
Q3 | $261K | Buy |
2,335
+1,387
| +146% | +$160K | ﹤0.01% | 4961 |
|
|
2015
Q2 | $96K | Buy |
948
+488
| +106% | +$50.5K | ﹤0.01% | 5611 |
|
|
2015
Q1 | $50K | Buy |
460
+321
| +231% | +$32.9K | ﹤0.01% | 5797 |
|
|
2014
Q4 | $13K | Buy |
139
+64
| +85% | +$5.46K | ﹤0.01% | 6162 |
|
|
2014
Q3 | $6K | Buy |
75
+44
| +142% | +$3.36K | ﹤0.01% | 6305 |
|
|
2014
Q2 | $2K | Sell |
31
-3,958
| -99% | -$308K | ﹤0.01% | 6400 |
|
|
2014
Q1 | $322K | Buy |
+3,989
| New | +$366K | ﹤0.01% | 4848 |
|
Other funds holding PLXP
Morgan Stanley's PLXP Position: Q2 2023 in Review
Morgan Stanley sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2023, closing a stake of 179,616 shares — an estimated $23.4K sold.
Morgan Stanley first reported a position in PLXP in Q1 2014 and held it in 37 quarters. The position peaked at $6.88M in Q4 2021. 4 funds tracked by Wall St. Rank hold PLXP as of Q2 2023.
- Morgan Stanley reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
- Morgan Stanley sold 179,616 PLx Pharma Inc. Common Stock shares in Q2 2023, an estimated $23.4K.
- Morgan Stanley first reported a position in PLx Pharma Inc. Common Stock in Q1 2014 and held it in 37 quarters.
- Morgan Stanley's PLx Pharma Inc. Common Stock position peaked at $6.88M in Q4 2021.
- 4 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2023.
Based on Morgan Stanley's 13F filing for Q2 2023, filed 14 Aug 2023.